back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-12-16 11:30 Tx date 2025-12-15 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-481,250
-250 vol $1,925 each |
14,050 | |
| Older filings | ||||||
| Filed 2024-12-22 12:02 Tx date 2024-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-41,762 vol |
2,197 | |
| Filed 2024-12-22 12:00 Tx date 2024-12-20 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,874
+6,250 vol $4.14 each |
14,300 | |
| Filed 2024-12-22 11:59 Tx date 2024-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-152,950 vol |
8,050 | |
| Filed 2024-05-28 14:20 Tx date 2024-05-27 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-408,758.625
-1,139 vol $358.88 each |
161,000 | |
| Filed 2024-02-21 11:33 Tx date 2024-02-20 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,921
+41,600 vol $0.3587 each |
43,959 | |
| Filed 2023-12-26 10:50 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,320
+136,000 vol $0.37 each |
162,139 | |
| Filed 2023-05-16 12:08 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,529,847
-1,818 vol $841.50 each |
26,139 | |
| Filed 2023-03-08 13:05 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-696,918.75
-545 vol $1,278 each |
27,957 | |
| Filed 2022-12-19 15:25 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,700
+15,000 vol $1.78 each |
28,502 | |
| Filed 2022-11-17 15:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
28,502 | |
| Filed 2022-10-25 18:23 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,644 vol |
2,359 | |
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
||
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
2,360 | |
| Filed 2022-10-12 17:48 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-324,074 vol |
13,502 | |
| Filed 2022-06-02 11:47 Tx date 2022-06-02 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-202,494.60
-13,636 vol $14.85 each |
337,576 | |
| Filed 2022-04-14 18:49 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,659
+14,160 vol $0.89 each |
59,003 | |
| Filed 2022-04-14 18:19 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,925
+22,720 vol $0.88 each |
||